Daliu Min
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
Papers in
-
- Circular RNAs in diseases 4
- Ubiquitin and proteasome pathways 3
- RNA modifications and cancer 3
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 4
- Cancer Genomics and Diagnostics 2
- Co-authors
- Zan Shen (22 shared papers)Yang Yao (20 shared papers)Aina He (14 shared papers)Wei‐Xiang Qi (11 shared papers)Kun Han (16 shared papers)Lina Tang (13 shared papers)Yuanjue Sun (10 shared papers)Feng Lin (8 shared papers)
- Journals
- PLoS ONE (4 papers)Acta Pharmacologica Sinica (3 papers)OncoTargets and Therapy (3 papers)Frontiers in Genetics (2 papers)BMC Cancer (2 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Daliu Min
46 papers receiving 994 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 188
- Oncology 239
- Pulmonary and Respiratory Medicine 254
- Molecular Biology 417
- Applied Microbiology and Biotechnology 10
Countries citing papers authored by Daliu Min
This map shows the geographic impact of Daliu Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daliu Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daliu Min more than expected).
Fields of papers citing papers by Daliu Min
This network shows the impact of papers produced by Daliu Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daliu Min. The network helps show where Daliu Min may publish in the future.
Co-authors
The 25 scholars most cited alongside Daliu Min, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 81 | |
| 2 | 2012 | 71 | |
| 3 | 2016 | 62 | |
| 4 | 2012 | 55 | |
| 5 | 2016 | 49 | |
| 6 | 2018 | 49 | |
| 7 | 2012 | 45 | |
| 8 | 2020 | 34 | |
| 9 | 2015 | 32 | |
| 10 | 2015 | 31 | |
| 11 | 2012 | 31 | |
| 12 | 2013 | 29 | |
| 13 | 2017 | 29 | |
| 14 | 2013 | 28 | |
| 15 | 2012 | 27 | |
| 16 | 2017 | 25 | |
| 17 | 2017 | 23 | |
| 18 | 2014 | 21 | |
| 19 | 2014 | 21 | |
| 20 | 2012 | 21 |
About Daliu Min
Daliu Min is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Cell Biology, having authored 48 papers that have together received 1.0k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (8 papers), Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (4 papers), Ubiquitin and proteasome pathways (3 papers), RNA modifications and cancer (3 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Cancer Research (188 citations), Oncology (239 citations), Pulmonary and Respiratory Medicine (254 citations), Molecular Biology (417 citations) and Applied Microbiology and Biotechnology (10 citations). Daliu Min has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Zan Shen, Yang Yao, Aina He, Wei‐Xiang Qi, Kun Han, Lina Tang, Yuanjue Sun, Feng Lin, Zhihua Gan and Shuchen Lin. Their work appears in journals such as PLoS ONE, Acta Pharmacologica Sinica, OncoTargets and Therapy, Frontiers in Genetics and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.